Skip to main content
Login
Contact
Subscribe
Search form
Search
The Decatur Daily Democrat
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Photos
Videos
Games
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Arqule Inc
(NQ:
ARQL
)
20.00
USD
UNCHANGED
Last Price
Updated: 5:01 PM EST, Jan 15, 2020
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Arqule Inc
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
These 2 Stocks Could Be 2020's Best Profit Opportunities
February 22, 2020
How do we find the top stock of 2020? The best performers in 2019 offer some clues.
Tags
NVAX
Market News
AAPL
From
Motley Fool
The 10 Best-Performing Micro-Cap Stocks of 2019
January 11, 2020
In 2019 the S&P 500 Index rose an astounding 29%. Much of that gain is the result of a horrible end to 2018 that saw stocks bottom the day before Christmas. Here were the 10 best-performing micro-cap...
Tags
Pharma/Biotech
From
Blogs - TalkMarkets
Dollar Tree Stock Is Down 20%, But Investors Should Reject Mini-Tender Offer
January 08, 2020
It's a good bet the buyer thinks the stock is going to go up.
Tags
MRK
DLTR
Market News
From
Motley Fool
These Were the 10 Best Stocks of 2019
January 06, 2020
Seven biotechs led the way.
Tags
DRRX
EVER
RCEL
From
Motley Fool
Why Biotech Stock ArQule Soared 108% in December
January 04, 2020
This cancer-drug developer received a buyout offer from a big pharmaceutical company.
Tags
MRK
Market News
ARQL
From
Motley Fool
Here are the best-performing Nasdaq stocks of 2019
December 27, 2019
AMD, Lam Research and KLA top the list.
Tags
NMRK
ACGL
LULU
From
MarketWatch
A Perspective On Biopharma's Record M&A Run In 2019
December 23, 2019
This year was a watershed one for biopharma M&A, with several multibillion-dollar deals announced thus far. M&A activity in ...
Tags
BMRN
ALNY
SRPT
From
Benzinga
These Were the 10 Best Healthcare Stocks of 2019
December 23, 2019
Helping people stricken with illness can be richly rewarding in more ways than one.
Tags
ARWR
ARQL
GH
From
Motley Fool
Why Aptose Biosciences Shares Are Jumping Today
December 18, 2019
Investors excited about the biotech's prospects are taking the opportunity to buy on the dip following the announcement of a new stock offering.
Tags
ARQL
Market News
APTO
From
Motley Fool
The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week
December 15, 2019
Biotech stocks were seen consolidating last week after advancing in the previous week. The iShares NASDAQ Biotechnology Index (NASDAQ: ...
Tags
Trading Ideas
General
Previews
From
Benzinga
Better Buy: Eli Lilly vs. Merck
December 14, 2019
Which of these two pharmaceutical giants is poised to produce healthier returns?
Tags
LLY
Market News
NVO
From
Motley Fool
Notable Thursday Option Activity: FOSL, ARQL, ATNX
December 12, 2019
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Fossil Group Inc (FOSL), where a total volume of 7,870 contracts has been traded...
Tags
Stocks
From
Market News Video
There’s more upside for biotech even after 24% gains in two months
December 12, 2019
Seven biotech stocks to consider buying.
Tags
NVS
ARQL
SAGE
From
MarketWatch
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
December 12, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
BHC
FLXN
KDMN
From
Benzinga
Hot Options Report For End Of Day - Wednesday, Dec. 11
December 11, 2019
Top tickers for end of day: DHR, ARQL, AAPL, F, GILD, FANG, PCG.
Tags
Options
From
Blogs - TalkMarkets
Why Merck, Sanofi News Helped This Biotech Rocket 31% Over Two Days
December 11, 2019
Principia Biopharma stock has rocketed 31% this week amid enthusiasm for its technology, BTK inhibition — highlighted by notable moves from pharmaceutical giants Merck and Sanofi.
From
Investor's Business Daily
Most Active Equity Options For Midday - Wednesday, Dec. 11
December 11, 2019
Top tickers for midday: AAPL, DHR, TSLA, BAC, BA, MU, FCX, NFLX, AMD, MSFT, BABA, F, PCG, HD, DIS, FANG, ROKU, GME, PTON, ARQL.
Tags
Options
From
Blogs - TalkMarkets
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
December 11, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
MDCO
RHHBY
KIDS
From
Benzinga
Why Biotech ETFs Are Surging To New Highs
December 10, 2019
We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharmaceutical companies are trying to gain an edge in the increasingly competitive...
Tags
ETFs
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Hot Options Report For End Of Day - Tuesday, Dec. 10
December 10, 2019
Top tickers for end of day: DHR, AAPL, ARQL, F, LPI, T.
Tags
Options
From
Blogs - TalkMarkets
Investors shift attention to next generation of CAR-T, new sickle cell treatments at major hematology meeting
December 10, 2019
A handful of sickle cell disease treatments and CAR-T therapies that treat cancer have been approved by the Food and Drug Administration in recent years, but a new crop of investigational therapies...
Tags
General
JNJ
ARQL
From
MarketWatch
Stocks That Hit 52-Week Highs On Tuesday
December 10, 2019
During Tuesday, 224 stocks hit new 52-week highs. Noteables: The largest company by market cap to hit a new 52-week high was ...
Tags
NLOK
XENE
DPMLF
From
Benzinga
Most Active Equity Options For Midday - Tuesday, Dec. 10
December 10, 2019
Top tickers for midday: AAPL, TSLA, DHR, AMD, NFLX, ARQL, BABA, T, FB, AMZN, ROKU, BAC, NVDA, MU, DIS, MSFT, BMY, SFIX, SQ, CGC.
Tags
Options
From
Blogs - TalkMarkets
Benzinga's Top Upgrades, Downgrades For December 10, 2019
December 10, 2019
Upgrades JP Morgan changed the rating for Adecoagro SA (NYSE: AGRO) from Neutral to Overweight. For the third quarter, Adecoagro ...
Tags
Financials
KRC
CHD
From
Benzinga
10 Biggest Price Target Changes For Tuesday
December 10, 2019
SunTrust Robinson Humphrey raised Hilton Hotels Corporation (NYSE: HLT) price target from $111 to $121. Hilton Hotels shares closed ...
Tags
CSX
NKE
ARQL
From
Benzinga
ArQule Reaches Analyst Target Price
December 10, 2019
In recent trading, shares of ArQule Inc. (ARQL) have crossed above the average analyst 12-month target price of $13.57, changing hands for $19.70/share..
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
December 10, 2019
The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week ...
Tags
ASRT
MTP
HTGM
From
Benzinga
80 Biggest Movers From Yesterday
December 10, 2019
Gainers Synthorx, Inc. (NASDAQ: THOR) shares jumped 170.5% to close at $67.71 on Monday after the company announced it would be ...
Tags
NERV
Trading Ideas
CNTG
From
Benzinga
Drugmakers have spent a record $342 billion on M&A in 2019
December 09, 2019
A string of multibillion-dollar pharmaceutical deals announced over the last week call attention to a record-setting year in which drugmakers and biotechs have spent $342 billion snapping up smaller...
Tags
XBIT
M&A
Health/Care
From
MarketWatch
What Happened in the Stock Market Today
December 09, 2019
Two big deals for cancer drug companies made news today. Merck plans to buy ArQule and Sanofi will pay up to buy Synthorx.
Tags
ARQL
SNY
Market News
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.